.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Argus Health
Chubb
Citi
UBS
McKesson
US Department of Justice
Baxter
Cerilliant
Boehringer Ingelheim

Generated: September 22, 2017

DrugPatentWatch Database Preview

TILADE Drug Profile

« Back to Dashboard

What is the patent landscape for Tilade, and what generic Tilade alternatives are available?

Tilade is a drug marketed by Sanofi Aventis Us and King Pharms Llc and is included in two NDAs.

The generic ingredient in TILADE is nedocromil sodium. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the nedocromil sodium profile page.

Summary for Tradename: TILADE

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list59
Clinical Trials: see list1
Patent Applications: see list1,723
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TILADE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
TILADE
nedocromil sodium
SOLUTION;INHALATION020750-001Oct 1, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
King Pharms Llc
TILADE
nedocromil sodium
AEROSOL, METERED;INHALATION019660-001Dec 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TILADE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc
TILADE
nedocromil sodium
AEROSOL, METERED;INHALATION019660-001Dec 30, 1992► Subscribe► Subscribe
King Pharms Llc
TILADE
nedocromil sodium
AEROSOL, METERED;INHALATION019660-001Dec 30, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Argus Health
Medtronic
Novartis
Fish and Richardson
Deloitte
McKinsey
Healthtrust
Julphar
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot